T 0433/24 (Stabilized vitamin D formulation / EIRGEN) of 26.02.2026
- European Case Law Identifier
- ECLI:EP:BA:2026:T043324.20260226
- Date of decision
- 26 February 2026
- Case number
- T 0433/24
- Online on
- 23 March 2026
- Petition for review of
- -
- Application number
- 14717038.5
- IPC class
- A61P 17/00A61P 11/00A61P 21/00A61P 13/00A61P 7/00A61P 1/00A61K 47/44A61P 9/00A61P 25/00A61P 5/00A61P 19/00A61K 9/48A61K 31/593A61P 3/00A61P 27/00A61K 9/20A61K 31/592A61K 47/38A61P 15/00A61K 9/28
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- STABILIZED MODIFIED RELEASE VITAMIN D FORMULATION AND METHOD OF ADMINISTRING SAME
- Applicant name
- EirGen Pharma Ltd.
- Opponent name
- DSM Nutritional Products AG
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(c)European Patent Convention Art 123(2)European Patent Convention Art 54(2)European Patent Convention Art 56Rules of procedure of the Boards of Appeal 2020 Art 012(1)(c)Rules of procedure of the Boards of Appeal 2020 Art 012(4)Rules of procedure of the Boards of Appeal 2020 Art 012(2)European Patent Convention Art 117(1)(d)
- Keywords
- Late-filed objection - admitted in first-instance proceedings (yes)
Late-filed objection - admitted (yes)
Taking of evidence - hearing witness
Amendments - added subject-matter (main request: yes)
Novelty - auxiliary request (yes)
Inventive step - auxiliary request (yes) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The decision under appeal is set aside.
The case is remitted to the opposition division with the order to maintain the patent on the basis of the claims of auxiliary request 1 filed with the statement of grounds of appeal and corresponding to auxiliary request 1 filed on 27 July 2023, and a description to be adapted.